English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Oligonucleotide-protamine-albumin nanoparticles: Protamine sulfate causes drastic size reduction

Mayer, G., Vogel, V., Weyermann, J., Lochmann, D., van den Broek, J. A., Tziatzios, C., et al. (2005). Oligonucleotide-protamine-albumin nanoparticles: Protamine sulfate causes drastic size reduction. Journal of Controlled Release, 106(1-2), 181-187. doi:10.1016/j.jconrel.2005.04.019.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Mayer, Gottfried1, Author
Vogel, Vitali1, Author
Weyermann, Jörg2, Author
Lochmann, Dirk2, Author
van den Broek, Jacomina A.1, Author
Tziatzios, Christos1, Author
Haase, Winfried3, Author           
Wouters, Daan4, Author
Schubert, Ulrich S.4, Author
Zimmer, Andreas5, Author
Kreuter, Jörg2, Author
Schubert, Dieter1, Author
Affiliations:
1Institut für Biophysik, Johann Wolfgang Goethe-Universität, 60590 Frankfurt am Main, Germany, ou_persistent22              
2Institut für Pharmazeutische Technologie, Johann Wolfgang Goethe-Universität, 60439 Frankfurt am Main, Germany, ou_persistent22              
3Department of Structural Biology, Max Planck Institute of Biophysics, Max Planck Society, ou_2068291              
4Laboratory of Macromolecular Chemistry and Nanoscience, Eindhoven University of Technology, NL-5600 MB Eindhoven, The Netherlands, ou_persistent22              
5Institut für Pharmazeutische Chemie und Pharmazeutische Technologie, Karl-Franzens-Universität, Schubertstrasse 6, 8010 Graz, Austria, ou_persistent22              

Content

show
hide
Free keywords: Nanoparticles; Phosphorothioates; Protamine sulfate; Human serum albumin; Cellular release
 Abstract: Nanoparticles prepared by self-assembly from oligonucleotides (ONs), protamine free base, and human serum albumin ("ternary proticles") are spheres of diameters around 200 nm. Substitution of the protamine free base by protamine sulfate leads to proticles of only around 40 nm in diameter with otherwise unchanged properties. The availability of drug delivery systems of very similar composition but grossly different size may be advantageous when dealing with cells which show size-dependent particle uptake. These nanoparticles are promising candidates for ON delivery to cells because of the following reasons: (1) They are stable for several hours in solutions of up to physiological ionic strength; (2) they are efficiently taken up by cells; (3) after cellular uptake, they easily release the ONs even when these are present as phosphorothioates.

Details

show
hide
Language(s): eng - English
 Dates: 2004-12-022005-04-202005-07-062005-08-18
 Publication Status: Issued
 Pages: 7
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: DOI: 10.1016/j.jconrel.2005.04.019
PMID: 16002173
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Journal of Controlled Release
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: Amsterdam : Elsevier
Pages: - Volume / Issue: 106 (1-2) Sequence Number: - Start / End Page: 181 - 187 Identifier: ISSN: 0168-3659
CoNE: https://pure.mpg.de/cone/journals/resource/954925484703